Ihr Broker

  • DAX 0,70
  • EUR/USD 0,50
  • GOLD 0,30

Nur Spreads

Keine Kommission

Jetzt registrieren

CFDs sind komplexe Instrumente und umfassen aufgrund der Hebelfinanzierung ein hohes Risiko, schnell Geld zu verlieren.

SHOP APOTHEKE EUROPE N.V., NL0012044747

SHOP APOTHEKE EUROPE N.V., NL0012044747

26.03.2020 - 11:06:52

???????SHOP APOTHEKE EUROPE COMMITS TO UN GLOBAL COMPACT STANDARDS.

MEDIA CONTACTS.

Trade and popular media: Sven Schirmer Tel: +49 221 99 53 44 31 Email: presse@shop-apotheke.com

Financial media: Bettina Fries Tel: +49 211 75 80 779 Email: presse@shop-apotheke.com

Investor relations: Carmen Herkenrath Tel.: +31 77 850 6109 Email: carmen.herkenrath@shop-apotheke.com

26.03.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language: English Company: SHOP APOTHEKE EUROPE N.V. Dirk Hartogweg 14 5928 LV Venlo

Netherlands Phone: 0800 - 200 800 300 Fax: 0800 - 90 70 90 20 E-mail: carmen.herkenrath@shop-apotheke.com Internet: www.shop-apotheke-europe.com ISIN: NL0012044747, DE000A19Y072 WKN: A2AR94, A19Y07 Indices: SDAX Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange EQS News ID: 1007789   End of News DGAP News Service

1007789  26.03.2020 

@ dgap.de